Partial long-term clinical improvement after a BCG challenge in systemic lupus erythematosus-prone mice

• Main Authors: Valentina P. Mora (Author), Francisco B. Quero (Author), Tays Troncoso-Bravo (Author), Claudia Orellana (Author), Patricia Pereira (Author), Juan P. Mackern-Oberti (Author), Samanta C. Funes (Author), Jorge A. Soto (Author), Karen Bohmwald (Author), Susan M. Bueno (Author), Alexis M. Kalergis (Author)
• Format: Book
• Published: Taylor & Francis Group, 2024-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Systemic Lupus Erythematosus (SLE) is an autoimmune disorder that causes a breakdown of immune tolerance. Current treatments mainly involve general immunosuppression, increasing the risk of infections. On the other hand, Bacillus Calmette-Guérin (BCG) has been investigated as a potential therapy fo...